126204001: Liothyronine sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Thyroid hormone\Liothyronine sodium

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Thyroid hormone\Liothyronine sodium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

33671018 Liothyronine sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

730137019 Liothyronine sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

820941000172118 liothyronine sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Liothyronine sodium	Is a	Product containing liothyronine (medicinal product)	false	Inferred relationship	Some
Liothyronine sodium	Is a	Liothyronine	false	Inferred relationship	Some
Liothyronine sodium	Is a	Thyroid hormone	true	Inferred relationship	Some
Liothyronine sodium	Is a	Liothyronine	false	Inferred relationship	Some
Liothyronine sodium	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Thyroid hormone (disposition)	true	Inferred relationship	Some
Liothyronine sodium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Liothyronine	true	Inferred relationship	Some
Liothyronine sodium	Is a	Hormone	false	Inferred relationship	Some
Liothyronine sodium	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Accidental liothyronine poisoning	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some
Accidental liothyronine overdose	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine sodium 20 microgram powder for solution for injection ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine sodium preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine sodium 5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine sodium 25 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine sodium 10mcg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liotrix preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Product containing levothyroxine sodium and liothyronine sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Accidental liothyronine poisoning	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some
Intentional liothyronine poisoning	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine poisoning of undetermined intent	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some
Allergy to liothyronine	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine overdose	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some	1
Intentional liothyronine overdose	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine overdose of undetermined intent	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some	1
Poisoning by liothyronine	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Liothyronine sodium 10mcg/mL injection solution 1mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some
Allergy to liothyronine	Causative agent (attribute)	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 25 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 25 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	2
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 5 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	2
Liothyronine sodium 25 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 20 microgram powder for solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	1
Liothyronine sodium 20 microgram powder for solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liothyronine sodium	Inferred relationship	Some	2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liothyronine sodium	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33671018	Liothyronine sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
730137019	Liothyronine sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
820941000172118	liothyronine sodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module